UBS UBS Initiates Coverage of Bruker With Buy Rating The bank said factors including Bruker's increasing exposure to consumables and pharma end markets as well as increased US federal funding would drive growth. Singular Genomics Ups IPO Target to $187M The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation. Sequencing Startup Singular Genomics Files for $100M IPO The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis. NanoString Technologies Prices $200M Public Offering The Seattle-based genomics technology firm said it intends to use the funds for working capital and general corporate purposes. NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent The company expects product and service revenue totaling $30.1 million, driven by higher instrument revenue, offset by declining consumables revenue. Sep 22, 2020 UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal May 12, 2016 Consumer Genomics Awareness High but Market Still Nascent, Survey Shows Premium Sep 20, 2012 Cepheid Provides Update on MDx Pipeline with Focus on CT/NG, TB, Oncology Premium Sep 23, 2011 Mass Spec Vendors Offer Takes on Top-Down Proteomics, UHPLC at UBS Conference Premium Sep 22, 2011 Cepheid Provides Update on Dx Menu Expansion; Oncology Plans Include Breast Cancer Recurrence Test Premium Sep 22, 2011 Epigenomics, GenturaDx Pitch Investors on Final Day of UBS Global Life Sciences Conference Sep 20, 2011 UBS Global Life Sciences Conference, Day 1: Meridian, Bruker, RainDance, Sequenom Sep 23, 2010 Bio-Rad to Launch First PCR-based MDx Platform in Coming Month, CEO Says Premium Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.